Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer – single hospital experience
Abstract Background Triple-negative breast cancer is a heterogeneous molecular subtype of BC. Pathological complete response (pCR) is an important surrogate marker for recurrence-free and overall survival. Aim of study The aim of this study was to evaluate clinical and pathological factors that are...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2023-03-01
|
| Col·lecció: | Hereditary Cancer in Clinical Practice |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s13053-023-00249-1 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|